COVID-19 Related Health and Infection Control Practices Among Dentists
- Conditions
- Severe Acute Respiratory Syndrome Coronavirus 2
- Interventions
- Other: No intervention
- Registration Number
- NCT04423770
- Lead Sponsor
- American Dental Association
- Brief Summary
As dentists begin reopening their practices during a global pandemic, the risk of COVID-19 infection that dentists face in providing dental care remains unknown. Estimating the occupational risk of COVID-19, and producing evidence on the types of infection control practices and dental practices that may affect COVID-19 risk, is therefore imperative. The goal of the proposed study is to understand U.S.-based dentists' health and dental-practice reactions to COVID-19. To estimate this, U.S-based dentists will be surveyed monthly. These findings could be used to describe the prevalence and incidence of COVID-19 among dentists, determine what infection control steps dentists take over time, and estimate whether infection control adherence in dental practice is related to COVID-19 incidence.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 2196
- Primary dental practice is in United States
- 18 years of age or older
- Dentist
•Answered "no" to ADA survey sent May 2020 that read "As part of ongoing efforts to monitor the effect of COVID-19 on the dental team, the ADA is interested in collecting data related to infection rates. Would you also be willing to participate in a separate, longitudinal study that would require you to report whether you or your staff have exhibited symptoms of COVID-19, and whether you have been tested or diagnosed? The study would be anonymous and under IRB protocols."
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description U.S. dentists No intervention Dentists in the United States
- Primary Outcome Measures
Name Time Method COVID-19 probable or confirmed case 18 months COVID-19 case as confirmed by clinician and/or detection of SARS-CoV-2 RNA or a specific antigen in a clinical specimen
- Secondary Outcome Measures
Name Time Method Anxiety 12 months Assessed using the Patient Health Questionnaire for Depression and Anxiety (PHQ-4). Two items scored 0 to 3 (total score of 0-6), with higher numbers indicating greater anxiety.
Depression 12 months Assessed using the Patient Health Questionnaire for Depression and Anxiety (PHQ-4). Two items scored 0 to 3 (total score of 0-6), with higher numbers indicating greater depressive symptoms.
Dental practice infection control efforts 12 months Self-reports of infection control efforts in the respondents' primary dental practices
Dentists' use of personal protective equipment 12 months Self-reports of personal protective equipment use
Trial Locations
- Locations (1)
American Dental Association
🇺🇸Chicago, Illinois, United States